With this approval, Zydus has obtained 415 regulatory clearances and filed 483 Abbreviated New Drug Applications (ANDAs) as ...
Zydus Lifesciences share price will remain in focus on March 6 after the company received final approval from USFDA for Dasatinib Tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback